108 related articles for article (PubMed ID: 316806)
1. Effect of anti-mouse type-1 interferon globulin on the evolution of Moloney sarcoma virus induced disease in mice.
Inglot AD; Inglot O; Zóltowska A; Oleszak E
Int J Cancer; 1979 Oct; 24(4):445-9. PubMed ID: 316806
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-interferon serum on growth and regression of Moloney sarcoma virus induced tumours in mice.
Inglot AD; Oleszak E; Inglot O
Acta Biol Med Ger; 1979; 38(5-6):829-35. PubMed ID: 525154
[TBL] [Abstract][Full Text] [Related]
3. Enchancement of leukemogenesis in mice after prolonged administration of anti-interferon or normal rabbit globulin.
Inglot AD; Chudzio T
Arch Virol; 1977; 55(1-2):67-75. PubMed ID: 921545
[TBL] [Abstract][Full Text] [Related]
4. Application of antisera to interferon in studying oncogenic viruses.
Inglot AD; Oleszak E
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):529-36. PubMed ID: 219809
[TBL] [Abstract][Full Text] [Related]
5. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
Basombrío MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
6. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
[No Abstract] [Full Text] [Related]
7. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
Powell TJ; Spann R; Nguyenduc M; Lamon EW
J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
[TBL] [Abstract][Full Text] [Related]
8. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
Epstein LB; Knight RA
Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
[TBL] [Abstract][Full Text] [Related]
9. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
10. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
Mayer AM; Basombrio MA; Pasqualini CD
Br J Cancer; 1980 Jun; 41(6):966-75. PubMed ID: 6252923
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
Wood GW
Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity of Moloney leukemia virus-induced T cel lymphomas.
Pepersack L; Lee JC; McEwan R; Ihle JN
J Immunol; 1980 Jan; 124(1):279-85. PubMed ID: 6965293
[No Abstract] [Full Text] [Related]
14. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
Kende M; Keys LD; Gaston M; Goldin A
Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
[TBL] [Abstract][Full Text] [Related]
15. Effect of non-steroidal anti-inflammatory drugs of Moloney sarcoma virus inoculated mice.
Inglot AD; Oleszak E
Experientia; 1978 Dec; 34(12):1615-7. PubMed ID: 729732
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
Lavrin DH; Herberman RB; Nunn M; Soares N
J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
[No Abstract] [Full Text] [Related]
17. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. VI. Polyoma virus infection.
Gresser I; Maury C; Kress C; Blangy D; Maunoury MT
Int J Cancer; 1979 Aug; 24(2):178-83. PubMed ID: 226483
[TBL] [Abstract][Full Text] [Related]
18. T cell-mediated immunity to oncornavirus-induced tumors. IV. Preliminary evidence for a specific suppression of anti-Moloney cell-mediated immune response by autoimmune T cells.
Leclerc JC; Plater C; Connan F; Debré P
Eur J Immunol; 1981 Jan; 11(1):45-7. PubMed ID: 6452279
[TBL] [Abstract][Full Text] [Related]
19. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.
Gresser I; Tovey MG; Maury C; Bandu MT
J Exp Med; 1976 Nov; 144(5):1316-23. PubMed ID: 186555
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
Leclerc JC; Gomard E; Levy JP
Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
